Artículo
FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: its Relationship With TGF-β1 and NF-κB Pathways
Besso, María José
; Rosso, Marina
; Lapyckyj, Lara
; Moiola, Cristian Pablo
; Matos, María Laura; Mercogliano, María Florencia
; Schillaci, Roxana
; Reventos, Jaume; Colas, Eva; Gil Moreno, Antonio; Wernicke, Alejandra; Orti, Roberto; Vazquez, Monica Hebe
Fecha de publicación:
12/2019
Editorial:
Lafrancone Luisa
Revista:
Frontiers in Oncology
ISSN:
2234-943X
e-ISSN:
2234-943X
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
Endometrial cancer (EC) is the second most common gynecological cancer worldwide. Myometrial invasion (MI) is a key event in EC dissemination. This study aimed to evaluate FXYD5/dysadherin (FXYD5/Dys) expression in EC tissue and uterine aspirate (UA) biopsies and to assess molecular/functional changes associated with its expression in cellular models.
Palabras clave:
ENDOMETRIAL CANCER
,
FXYD5/Dys
,
TGF-β1
,
NF-κB
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(IBYME)
Articulos de INST.DE BIOLOGIA Y MEDICINA EXPERIMENTAL (I)
Articulos de INST.DE BIOLOGIA Y MEDICINA EXPERIMENTAL (I)
Citación
Besso, María José; Rosso, Marina; Lapyckyj, Lara; Moiola, Cristian Pablo; Matos, María Laura; et al.; FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: its Relationship With TGF-β1 and NF-κB Pathways; Lafrancone Luisa; Frontiers in Oncology; 9; 12-2019; 1306-1306
Compartir
Altmétricas